二甲双胍与吡格列酮治疗2型糖尿病合并冠心病的临床效果分析
Clinical effect analysis of metformin and pioglitazone in treatment of type 2 diabetes mellitus complicated with coronary heart disease
ES评分 0
| DOI |
10.12208/j.ijcr.20240489 |
| 刊名 |
International Journal of Clinical Research
|
| 年，卷(期) |
2024, 8(11) |
| 作者 |
|
| 作者单位 |
广东省韶关市新丰县人民医院 广东韶关 ;
;
|
| 摘要 |
研究本文纳入的对象采取二甲双胍和吡格列酮治疗产生的作用。方法 时间为2023年1月-2024年1月。对象一共有80例，分组方式为随机数表分组，分组内容为对照组-40例-二甲双胍单独治疗。观察组-40例-二甲双胍+吡格列酮治疗。结果 观察组各指标情况均更佳（P<0.05）。不良反应发生率未见明显差异（P＞0.05）。结论 二甲双胍与吡格列酮治疗2型糖尿病合并冠心病的效果较佳，能够改善血糖代谢指标水平，改善冠脉损伤程度，提高整体治疗效果，值得推广采纳。
|
| Abstract |
Objective To study the effects of metformin and pioglitazone on the subjects included in this article. Methods The time was 2023.1-2024.1. There were 80 subjects in total, and the grouping method was random number table grouping. The grouping content was control group-40 cases-metformin alone treatment. Observation group-40 cases-metformin + pioglitazone treatment. Results All indicators in the observation group were better (P<0.05). There was no significant difference in the incidence of adverse reactions (P＞0.05). Conclusion Metformin and pioglitazone have better effects in the treatment of type 2 diabetes combined with coronary heart disease, can improve the level of blood sugar metabolism indicators, improve the degree of coronary artery damage, and improve the overall treatment effect, which is worthy of promotion and adoption.
|
| 关键词 |
二甲双胍；吡格列酮；2型糖尿病合并冠心病；治疗总有效率
|
| KeyWord |
Metformin; Pioglitazone; Type 2 diabetes combined with coronary heart disease; Total effective rate of treatment
|
| 基金项目 |
|
| 页码 |
144-146 |
成世炬*,罗文恒.
二甲双胍与吡格列酮治疗2型糖尿病合并冠心病的临床效果分析 [J].
国际临床研究杂志.
2024; 8; (11).
144 - 146.